Literature DB >> 12569895

WHO/CONRAD technical consultation on nonoxynol-9, World Health Organization, Geneva, 9-10 October 2001: summary report.

.   

Abstract

This report summarises the evidence presented to a technical consultation on the safety of N-9 and its effectiveness for protection against pregnancy, sexually transmitted infections and HIV, organized by the World Health Organization Department of Reproductive Health and Research with CONRAD in October 2001. Key conclusions from the meeting include: 1. Although Nonoxynol-9 has been shown to increase the risk of HIV infection when used frequently by women at high risk of infection, it remains a contraceptive option for women at low risk. 2. Nonoxynol-9 offers no protection against sexually transmitted infections such as gonorrhoea or chlamydia. 3. There is no evidence that condoms lubricated with nonoxynol-9 are any more effective in preventing pregnancy or infection than condoms lubricated with silicone, and such condoms should no longer be promoted. However, it is better to use a nonoxynol-9 lubricated condom than no condom at all. 4. Nonoxynol-9 should not be used rectally.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12569895     DOI: 10.1016/s0968-8080(02)00085-x

Source DB:  PubMed          Journal:  Reprod Health Matters        ISSN: 0968-8080


  11 in total

Review 1.  Contraception and abortion.

Authors:  Sam Rowlands
Journal:  J R Soc Med       Date:  2007-10       Impact factor: 5.344

2.  Automated segmentation algorithm for detection of changes in vaginal epithelial morphology using optical coherence tomography.

Authors:  Shahab Chitchian; Kathleen L Vincent; Gracie Vargas; Massoud Motamedi
Journal:  J Biomed Opt       Date:  2012-11       Impact factor: 3.170

3.  Efficacy and toxicity of zinc salts as candidate topical microbicides against vaginal herpes simplex virus type 2 infection.

Authors:  Nigel Bourne; Rachael Stegall; Raquel Montano; Michael Meador; Lawrence R Stanberry; Gregg N Milligan
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

4.  High resolution imaging of epithelial injury in the sheep cervicovaginal tract: a promising model for testing safety of candidate microbicides.

Authors:  Kathleen L Vincent; Nigel Bourne; Brent A Bell; Gracie Vargas; Alai Tan; Daniel Cowan; Lawrence R Stanberry; Susan L Rosenthal; Massoud Motamedi
Journal:  Sex Transm Dis       Date:  2009-05       Impact factor: 2.830

5.  Optical coherence tomography for assessment of microbicide safety in a small animal model.

Authors:  Brent A Bell; Kathleen L Vincent; Nigel Bourne; Gracie Vargas; Massoud Motamedi
Journal:  J Biomed Opt       Date:  2013-04       Impact factor: 3.170

6.  Appropriateness of hydroxyethylcellulose gel as a placebo control in vaginal microbicide trials: a comparison of the two control arms of HPTN 035.

Authors:  Barbra A Richardson; Cliff Kelly; Gita Ramjee; Thomas Fleming; Bonus Makanani; Sarah Roberts; Petina Musara; Nkhafwire Mkandawire; Thomas Moench; Anne Coletti; Lydia Soto-Torres; Salim A Karim
Journal:  J Acquir Immune Defic Syndr       Date:  2013-05-01       Impact factor: 3.731

7.  China needs safe and effective microbicides for preventing sexual transmission of HIV.

Authors:  Shibo Jiang; Shuwen Liu; Alan Stone
Journal:  Lancet Infect Dis       Date:  2006-11       Impact factor: 25.071

8.  Prevention of genital herpes in a guinea pig model using a glycoprotein D-specific single chain antibody as a microbicide.

Authors:  Jianmin Chen; Sanat K Davé; Anthony Simmons
Journal:  Virol J       Date:  2004-11-23       Impact factor: 4.099

Review 9.  Use of technology in supporting goal setting in rehabilitation for adults: a scoping review.

Authors:  Carla Strubbia; William Mark Magnus Levack; Rebecca Grainger; Kayoko Takahashi; Kounosuke Tomori
Journal:  BMJ Open       Date:  2020-11-10       Impact factor: 2.692

10.  Spermicidal and contraceptive potential of desgalactotigonin: a prospective alternative of nonoxynol-9.

Authors:  Debanjana Chakraborty; Arindam Maity; Tarun Jha; Nirup Bikash Mondal
Journal:  PLoS One       Date:  2014-09-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.